Yue-xian Hou

1.8k total citations
18 papers, 1.6k citations indexed

About

Yue-xian Hou is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yue-xian Hou has authored 18 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yue-xian Hou's work include Drug Transport and Resistance Mechanisms (9 papers), Cystic Fibrosis Research Advances (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Yue-xian Hou is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Cystic Fibrosis Research Advances (5 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Yue-xian Hou collaborates with scholars based in United States, Canada and Belgium. Yue-xian Hou's co-authors include John R. Riordan, Xiu-Bao Chang, Liying Cui, Timothy J. Jensen, Joseph A. Tabcharani, Johanna M. Rommens, John W. Hanrahan, Melinda A. Loo, Andrei A. Aleksandrov and Lap-Chee Tsui and has published in prestigious journals such as Nature, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Yue-xian Hou

18 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yue-xian Hou United States 14 811 727 420 213 175 18 1.6k
Xiu-Bao Chang United States 23 1.5k 1.9× 916 1.3× 730 1.7× 207 1.0× 183 1.0× 33 2.5k
Liying Cui United States 22 1.1k 1.4× 1.3k 1.8× 389 0.9× 270 1.3× 170 1.0× 29 2.1k
Andrei A. Aleksandrov United States 27 1.3k 1.7× 1.8k 2.5× 359 0.9× 196 0.9× 137 0.8× 46 2.5k
Luba A. Aleksandrov United States 20 938 1.2× 1.1k 1.5× 292 0.7× 75 0.4× 109 0.6× 29 1.5k
Kai Du Canada 16 976 1.2× 1.4k 1.9× 115 0.3× 376 1.8× 68 0.4× 23 2.0k
Ikram El Yazidi‐Belkoura France 22 1.0k 1.3× 142 0.2× 195 0.5× 112 0.5× 271 1.5× 36 1.6k
Thomas A. Rado United States 17 423 0.5× 276 0.4× 149 0.4× 46 0.2× 88 0.5× 34 942
Ulrich Salzer Austria 18 791 1.0× 230 0.3× 59 0.1× 443 2.1× 31 0.2× 34 1.4k
Kathy Kamath United States 17 781 1.0× 122 0.2× 556 1.3× 619 2.9× 28 0.2× 34 1.5k
Mayumi Sasaki Japan 17 484 0.6× 171 0.2× 127 0.3× 60 0.3× 31 0.2× 43 912

Countries citing papers authored by Yue-xian Hou

Since Specialization
Citations

This map shows the geographic impact of Yue-xian Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue-xian Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue-xian Hou more than expected).

Fields of papers citing papers by Yue-xian Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yue-xian Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue-xian Hou. The network helps show where Yue-xian Hou may publish in the future.

Co-authorship network of co-authors of Yue-xian Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yue-xian Hou. A scholar is included among the top collaborators of Yue-xian Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yue-xian Hou. Yue-xian Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Xu, Qinqin, et al.. (2017). CRISPR/Cas9-Mediated Three Nucleotide Insertion Corrects a Deletion Mutation in MRP1/ABCC1 and Restores Its Proper Folding and Function. Molecular Therapy — Nucleic Acids. 7. 429–438. 3 indexed citations
2.
Xu, Qinqin, Yue-xian Hou, Paul R. Langlais, et al.. (2016). Expression of the cereblon binding protein argonaute 2 plays an important role for multiple myeloma cell growth and survival. BMC Cancer. 16(1). 297–297. 35 indexed citations
3.
Billet, Arnaud, Yanlin Jia, Timothy J. Jensen, et al.. (2015). Potential sites of CFTR activation by tyrosine kinases. Channels. 10(3). 247–251. 13 indexed citations
4.
Yang, Runying, et al.. (2011). Glutamine residues in Q-loops of multidrug resistance protein MRP1 contribute to ATP binding via interaction with metal cofactor. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1808(7). 1790–1796. 12 indexed citations
5.
Hou, Yue-xian, Kanagaraj Palaniyandi, Paul M. Magtibay, et al.. (2009). Effects of Putative Catalytic Base Mutation E211Q on ABCG2-Mediated Methotrexate Transport. Biochemistry. 48(38). 9122–9131. 13 indexed citations
6.
Chang, Xiu-Bao, April Mengos, Yue-xian Hou, et al.. (2008). Role of N-linked oligosaccharides in the biosynthetic processing of the cystic fibrosis membrane conductance regulator. Journal of Cell Science. 121(17). 2814–2823. 65 indexed citations
7.
Cui, Liying, Luba A. Aleksandrov, Xiu-Bao Chang, et al.. (2006). Domain Interdependence in the Biosynthetic Assembly of CFTR. Journal of Molecular Biology. 365(4). 981–994. 182 indexed citations
8.
9.
Yang, Runying, Ali McBride, Yue-xian Hou, Aaron D. Goldberg, & Xiu-Bao Chang. (2005). Nucleotide dissociation from NBD1 promotes solute transport by MRP1. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1668(2). 248–261. 19 indexed citations
10.
11.
Hou, Yue-xian, Liying Cui, John R. Riordan, & Xiu-Bao Chang. (2002). ATP Binding to the First Nucleotide-binding Domain of Multidrug Resistance Protein MRP1 Increases Binding and Hydrolysis of ATP and Trapping of ADP at the Second Domain. Journal of Biological Chemistry. 277(7). 5110–5119. 52 indexed citations
12.
Hou, Yue-xian, et al.. (2000). Allosteric Interactions between the Two Non-equivalent Nucleotide Binding Domains of Multidrug Resistance Protein MRP1. Journal of Biological Chemistry. 275(27). 20280–20287. 124 indexed citations
13.
Chang, Xiu-Bao, Liying Cui, Yue-xian Hou, et al.. (1999). Removal of Multiple Arginine-Framed Trafficking Signals Overcomes Misprocessing of ΔF508 CFTR Present in Most Patients with Cystic Fibrosis. Molecular Cell. 4(1). 137–142. 127 indexed citations
14.
Loo, Melinda A., et al.. (1998). Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. The EMBO Journal. 17(23). 6879–6887. 313 indexed citations
15.
Chang, Xiu-Bao, Yue-xian Hou, & John R. Riordan. (1998). Stimulation of ATPase Activity of Purified Multidrug Resistance-associated Protein by Nucleoside Diphosphates. Journal of Biological Chemistry. 273(37). 23844–23848. 33 indexed citations
16.
Chang, Xiu-Bao, Yue-xian Hou, & John R. Riordan. (1997). ATPase Activity of Purified Multidrug Resistance-associated Protein. Journal of Biological Chemistry. 272(49). 30962–30968. 126 indexed citations
17.
Linsdell, Paul, Joseph A. Tabcharani, Johanna M. Rommens, et al.. (1997). Permeability of Wild-Type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channels to Polyatomic Anions. The Journal of General Physiology. 110(4). 355–364. 177 indexed citations
18.
Tabcharani, Joseph A., Johanna M. Rommens, Yue-xian Hou, et al.. (1993). Multi-ion pore behaviour in the CFTR chloride channel. Nature. 366(6450). 79–82. 218 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiu-Bao Chang Breakdown of academic impact, for papers by Liying Cui Breakdown of academic impact, for papers by Andrei A. Aleksandrov Breakdown of academic impact, for papers by Luba A. Aleksandrov Breakdown of academic impact, for papers by Kai Du Breakdown of academic impact, for papers by Ikram El Yazidi‐Belkoura Breakdown of academic impact, for papers by Thomas A. Rado Breakdown of academic impact, for papers by Ulrich Salzer Breakdown of academic impact, for papers by Kathy Kamath Breakdown of academic impact, for papers by Mayumi Sasaki
Rankless by CCL
2026